|
|
Volumn 18, Issue 12, 1999, Pages 1101-1102
|
|
An update on the oxazolidinone antibiotics
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA LACTAM ANTIBIOTIC;
CL 331002;
CLINAFLOXACIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
EPEREZOLID;
GENTAMICIN;
GLYCOPEPTIDE;
LINEZOLID;
METICILLIN;
N [[3 (4 ACETYLPHENYL) 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE;
N [[3 [4 (METHYLSULFINYL)PHENYL] 2 OXO 5 OXAZOLIDINYL]METHYL]ACETAMIDE;
ORITAVANCIN;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
PROTEIN SYNTHESIS INHIBITOR;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
DRUG ACTIVITY;
DRUG ADMINISTRATION ROUTE;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG INACTIVATION;
DRUG INDUCED DISEASE;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG SAFETY;
ENTEROCOCCUS;
ENTEROCOCCUS FAECIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
STAPHYLOCOCCUS;
STREPTOCOCCUS;
STREPTOCOCCUS PNEUMONIAE;
|
|
EID: 0032783954
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-199912000-00015 Document Type: Short Survey |
|
Times cited : (8)
|
|
References (15)
|
